Dalotuzumab is a humanized monoclonal antibody that targets IGF-1R. Dalotuzumab has been used in the research of various cancers such as breast cancer, non small cell lung cancer, and metastatic colorectal cancer.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.